Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Clinical trial NCT06993506 · RECRUITING
Trial details
- NCT number
- NCT06993506
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-28
- Primary completion
- 2027-08-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.